(CercleFinance.com) – OrbiMed Advisors LLC and OrbiMed Capital LLC, acting in concert on behalf of funds, declared to the AMF that they crossed downwards, on February 24, the thresholds of 10% of the capital and voting rights of Lysogene, and hold 9.52% of the capital and voting rights.
This crossing of thresholds results from a sale of Lysogene shares on the market. The holding of the companies OrbiMed Advisors LLC and OrbiMed Capital LLC, acting in concert on behalf of funds, amounted to 9.09% of the capital and voting rights on the date.